Aria Pharmaceuticals (formally known as twoXAR) improves drug discovery success rates and reduces years in development by combining AI with our high-quality data.
Many companies are integrating AI into their drug discovery pipeline with our high-quality data. Learn how Aria Pharmaceuticals accomplishes this.
Stop wasting years in drug development with low success rates. Aria Pharmaceuticals utilizes AI with our high-quality data to get the results they need.
"DrugBank has a powerful combination of data depth and breadth - that’s what we focus on to power our AI solutions."
- Aaron Daugherty, VP of Discovery Aria Pharmaceuticals
We hope you enjoy using DrugBank. Read how Aria Pharmaceuticals combines AI with our high-quality data to improve drug discovery success rates.
Aria Pharmaceuticals (formally known as twoXAR) Pharmaceuticals, a drug development and discovery company, uses DrugBank to assist in its artificial intelligence (AI) solutions.
We chatted with Aaron Daugherty of Aria Pharmaceuticals to discuss AI in the drug discovery industry, and how DrugBank’s structured database plays a role.
In this white paper, we cover: